niacinamide and 1-methyl-4-phenylpyridinium

niacinamide has been researched along with 1-methyl-4-phenylpyridinium in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's5 (55.56)18.2507
2000's2 (22.22)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holohan, PD; Ross, CR; Sokol, PP1
Griffiths, HR; Lunec, J; Willets, JM; Williams, AC1
Beal, MF; Henshaw, DR; Matthews, RT; Schulz, JB1
Beal, MF; Fallon, J; Hyman, BT; Matthews, RT1
Ullrich, KJ1
Beier, DR; Green, RM; Lo, K; Sterritt, C1
Conway, SJ; Ganapathy, ME; Ganapathy, V; Huang, W; Kekuda, R; Leibach, FH; Wang, H; Wu, X1
Akaike, A; Katsuki, H; Kume, T; Kurimoto, E; Okawara, M; Shibata, H1
Aravindan, S; Austen, BM; Evans, EA; Kadampeswaran, A; Levy, ER; Parsons, RB; Ramsden, DB; Sandhu, KK; Thomas, MG1

Reviews

1 review(s) available for niacinamide and 1-methyl-4-phenylpyridinium

ArticleYear
Renal transporters for organic anions and organic cations. Structural requirements for substrates.
    The Journal of membrane biology, 1997, Jul-15, Volume: 158, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Anions; Cations; Choline; Dicarboxylic Acids; Humans; Ion Transport; Kidney; Kinetics; Niacinamide; p-Aminohippuric Acid; Sulfates; Tetraethylammonium; Tetraethylammonium Compounds

1997

Other Studies

8 other study(ies) available for niacinamide and 1-methyl-4-phenylpyridinium

ArticleYear
The neurotoxins 1-methyl-4-phenylpyridinium and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine are substrates for the organic cation transporter in renal brush border membrane vesicles.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 242, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Cations; Dogs; Kidney Cortex; Microvilli; Neurotoxins; Niacinamide; p-Aminohippuric Acid; Pyridines; Pyridinium Compounds; Structure-Activity Relationship; Valinomycin

1987
Neurotoxicity of nicotinamide derivatives: their role in the aetiology of Parkinson's disease.
    Biochemical Society transactions, 1993, Volume: 21 ( Pt 3), Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Cell Survival; Humans; Isomerism; Kinetics; L-Lactate Dehydrogenase; Neuroblastoma; Neurotoxins; Niacinamide; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rotenone; Tumor Cells, Cultured

1993
Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases.
    Neuroscience, 1996, Volume: 71, Issue:4

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Anticonvulsants; Coenzymes; Cyclic N-Oxides; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Free Radicals; Lamotrigine; Male; Malonates; Memantine; Mitochondria; Nervous System Diseases; Neuroprotective Agents; Neurotoxins; Niacinamide; Nitro Compounds; Nitrogen Oxides; Propionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Spin Labels; Thallium; Triazines; Ubiquinone

1996
MPP+ produces progressive neuronal degeneration which is mediated by oxidative stress.
    Experimental neurology, 1997, Volume: 144, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Coenzymes; Cyclic N-Oxides; Dopamine Agents; Drug Combinations; Ions; Male; Nerve Degeneration; Niacinamide; Nitrogen Oxides; Oxidative Stress; Rats; Rats, Sprague-Dawley; Spin Labels; Substantia Nigra; Time Factors; Ubiquinone

1997
Cloning and functional expression of a mouse liver organic cation transporter.
    Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:5

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Carrier Proteins; Cations; Choline; Cloning, Molecular; Female; Kinetics; Liver; Membrane Potentials; Membrane Proteins; Mice; Molecular Sequence Data; Niacinamide; Oocytes; Organic Cation Transporter 1; Protons; Tetraethylammonium; Xenopus laevis

1999
Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney.
    American journal of physiology. Renal physiology, 2000, Volume: 279, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amiloride; Animals; Binding, Competitive; Carbon Radioisotopes; Cations; Cloning, Molecular; DNA-Binding Proteins; DNA, Complementary; Dopamine Agents; Exons; Gene Expression Regulation; HeLa Cells; Herbicides; Humans; In Situ Hybridization; Introns; Kidney; Mice; Niacinamide; Octamer Transcription Factor-3; Oocytes; Pigment Epithelium of Eye; RNA, Messenger; Tetraethylammonium; Transcription Factors; Tritium; Xenopus laevis

2000
Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults.
    Biochemical pharmacology, 2007, Feb-15, Volume: 73, Issue:4

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Animals, Newborn; Antioxidants; Cell Survival; Cytotoxins; DNA Damage; Dopamine; Dose-Response Relationship, Drug; Glutathione; Mesencephalon; Methylnitronitrosoguanidine; Neurons; Neuroprotective Agents; Niacinamide; Organ Culture Techniques; Quercetin; Rats; Rats, Wistar; Resveratrol; Sirtuin 1; Sirtuins; Sodium Azide; Stilbenes; Thrombin; Tumor Suppressor Protein p53

2007
The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of Complex I inhibitors.
    The Biochemical journal, 2011, May-15, Volume: 436, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Adenosine Triphosphate; Cell Line, Tumor; Electron Transport Complex I; Humans; NADH Dehydrogenase; Neuroblastoma; Niacinamide; Nicotinamide N-Methyltransferase

2011